Literature DB >> 21734779

Familial aggregation in inflammatory bowel disease: is it genes or environment?

Tiago Nunes1, Gionata Fiorino, Silvio Danese, Miquel Sans.   

Abstract

Inflammatory bowel disease (IBD) develops in genetically susceptible individuals due to the influence of environmental factors, leading to an abnormal recognition of microbiota antigens by the innate immune system which triggers an exaggerated immune response and subsequent bowel tissue damage. IBD has been more frequently found in families, an observation that could be due to either genetic, environmental or both types of factors present in these families. In addition to expanding our knowledge on IBD pathogenesis, defining the specific contribution to familial IBD of each one of these factors might have also clinical usefulness. We review the available evidence on familial IBD pathogenesis.

Entities:  

Keywords:  Environmental factors; Familial aggregation; Familial clustering; Genetics; Genome wide association studies; Inflammatory bowel disease

Mesh:

Substances:

Year:  2011        PMID: 21734779      PMCID: PMC3123468          DOI: 10.3748/wjg.v17.i22.2715

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  103 in total

1.  Contribution of genetic and environmental factors in the pathogenesis of Crohn's disease in a large family with multiple cases.

Authors:  Marie Joossens; Marc Simoens; Séverine Vermeire; Xavier Bossuyt; Karel Geboes; Paul Rutgeerts
Journal:  Inflamm Bowel Dis       Date:  2007-05       Impact factor: 5.325

2.  Are there any differences in phenotype or disease course between familial and sporadic cases of inflammatory bowel disease? Results of a population-based follow-up study.

Authors:  Magne Henriksen; Jørgen Jahnsen; Idar Lygren; Morten H Vatn; Bjørn Moum
Journal:  Am J Gastroenterol       Date:  2007-06-15       Impact factor: 10.864

3.  The risk of developing Crohn's disease after an appendectomy: a population-based cohort study in Sweden and Denmark.

Authors:  Gilaad G Kaplan; Bo V Pedersen; Roland E Andersson; Bruce E Sands; Joshua Korzenik; Morten Frisch
Journal:  Gut       Date:  2007-05-09       Impact factor: 23.059

4.  Smoking and inflammatory bowel disease: trends in familial and sporadic cohorts.

Authors:  Jeffrey A Tuvlin; Sania S Raza; Samuel Bracamonte; Christina Julian; Stephen B Hanauer; Dan L Nicolae; Andrea C King; Judy H Cho
Journal:  Inflamm Bowel Dis       Date:  2007-05       Impact factor: 5.325

5.  Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis.

Authors:  John D Rioux; Ramnik J Xavier; Kent D Taylor; Mark S Silverberg; Philippe Goyette; Alan Huett; Todd Green; Petric Kuballa; M Michael Barmada; Lisa Wu Datta; Yin Yao Shugart; Anne M Griffiths; Stephan R Targan; Andrew F Ippoliti; Edmond-Jean Bernard; Ling Mei; Dan L Nicolae; Miguel Regueiro; L Philip Schumm; A Hillary Steinhart; Jerome I Rotter; Richard H Duerr; Judy H Cho; Mark J Daly; Steven R Brant
Journal:  Nat Genet       Date:  2007-04-15       Impact factor: 38.330

6.  Familial Crohn's disease in Belgium: pedigrees, temporal relationships among cases, and family histories.

Authors:  Herbert J Van Kruiningen; Marie Joossens; Severine Vermeire; Sofie Joossens; Stéphane Debeugny; Corinne Gower-Rousseau; Antoine Cortot; Jean-Frédéric Colombel; Paul Rutgeerts; Robert Vlietinck
Journal:  J Clin Gastroenterol       Date:  2007-07       Impact factor: 3.062

Review 7.  The role of genetics in inflammatory bowel disease.

Authors:  Liesbet Henckaerts; Carolina Figueroa; Séverine Vermeire; Miquel Sans
Journal:  Curr Drug Targets       Date:  2008-05       Impact factor: 3.465

8.  A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1.

Authors:  Jochen Hampe; Andre Franke; Philip Rosenstiel; Andreas Till; Markus Teuber; Klaus Huse; Mario Albrecht; Gabriele Mayr; Francisco M De La Vega; Jason Briggs; Simone Günther; Natalie J Prescott; Clive M Onnie; Robert Häsler; Bence Sipos; Ulrich R Fölsch; Thomas Lengauer; Matthias Platzer; Christopher G Mathew; Michael Krawczak; Stefan Schreiber
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

9.  Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility.

Authors:  Miles Parkes; Jeffrey C Barrett; Natalie J Prescott; Mark Tremelling; Carl A Anderson; Sheila A Fisher; Roland G Roberts; Elaine R Nimmo; Fraser R Cummings; Dianne Soars; Hazel Drummond; Charlie W Lees; Saud A Khawaja; Richard Bagnall; Denis A Burke; Catherine E Todhunter; Tariq Ahmad; Clive M Onnie; Wendy McArdle; David Strachan; Graeme Bethel; Claire Bryan; Cathryn M Lewis; Panos Deloukas; Alastair Forbes; Jeremy Sanderson; Derek P Jewell; Jack Satsangi; John C Mansfield; Lon Cardon; Christopher G Mathew
Journal:  Nat Genet       Date:  2007-06-06       Impact factor: 38.330

10.  Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4.

Authors:  Cécile Libioulle; Edouard Louis; Sarah Hansoul; Cynthia Sandor; Frédéric Farnir; Denis Franchimont; Séverine Vermeire; Olivier Dewit; Martine de Vos; Anna Dixon; Bruno Demarche; Ivo Gut; Simon Heath; Mario Foglio; Liming Liang; Debby Laukens; Myriam Mni; Diana Zelenika; André Van Gossum; Paul Rutgeerts; Jacques Belaiche; Mark Lathrop; Michel Georges
Journal:  PLoS Genet       Date:  2007-03-05       Impact factor: 5.917

View more
  18 in total

1.  Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil.

Authors:  José Miguel Luz Parente; Claudio Saddy Rodrigues Coy; Viriato Campelo; Mírian Perpétua Palha Dias Parente; Leonardo Araújo Costa; Renata Mendes da Silva; Celso Stephan; José Murilo Robilotta Zeitune
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

Review 2.  Etiology of inflammatory bowel disease: a unified hypothesis.

Authors:  Xiaofa Qin
Journal:  World J Gastroenterol       Date:  2012-04-21       Impact factor: 5.742

Review 3.  Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.

Authors:  Cristina-Sorina Cătană; Ioana Berindan Neagoe; Vasile Cozma; Cristian Magdaş; Flaviu Tăbăran; Dan Lucian Dumitraşcu
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

4.  Association of fucosyltransferase 2 gene variants with ulcerative colitis in Han and Uyghur patients in China.

Authors:  Ayinuer Aheman; He-Sheng Luo; Feng Gao
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

Review 5.  Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets.

Authors:  Fiorella Biasi; Gabriella Leonarduzzi; Patricia I Oteiza; Giuseppe Poli
Journal:  Antioxid Redox Signal       Date:  2013-03-01       Impact factor: 8.401

Review 6.  Cell death and inflammatory bowel diseases: apoptosis, necrosis, and autophagy in the intestinal epithelium.

Authors:  Tiago Nunes; Claudio Bernardazzi; Heitor S de Souza
Journal:  Biomed Res Int       Date:  2014-07-14       Impact factor: 3.411

Review 7.  Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence.

Authors:  Sanghamitra M Misra
Journal:  Children (Basel)       Date:  2014-08-25

8.  Low hygiene and exposure to infections may be associated with increased risk for ulcerative colitis in a North Indian population.

Authors:  Ajit Sood; Devendra Amre; Vandana Midha; Suresh Sharma; Neena Sood; Amandeep Thara; Manu Bansal; Garima Juyal; Bittianda Kuttapa Thelma; Ernest Seidman
Journal:  Ann Gastroenterol       Date:  2014

Review 9.  Interleukin-33 and inflammatory bowel diseases: lessons from human studies.

Authors:  Tiago Nunes; Claudio Bernardazzi; Heitor S de Souza
Journal:  Mediators Inflamm       Date:  2014-02-20       Impact factor: 4.711

10.  Genetic sharing and heritability of paediatric age of onset autoimmune diseases.

Authors:  Yun R Li; Sihai D Zhao; Jin Li; Jonathan P Bradfield; Maede Mohebnasab; Laura Steel; Julie Kobie; Debra J Abrams; Frank D Mentch; Joseph T Glessner; Yiran Guo; Zhi Wei; John J Connolly; Christopher J Cardinale; Marina Bakay; Dong Li; S Melkorka Maggadottir; Kelly A Thomas; Haijun Qui; Rosetta M Chiavacci; Cecilia E Kim; Fengxiang Wang; James Snyder; Berit Flatø; Øystein Førre; Lee A Denson; Susan D Thompson; Mara L Becker; Stephen L Guthery; Anna Latiano; Elena Perez; Elena Resnick; Caterina Strisciuglio; Annamaria Staiano; Erasmo Miele; Mark S Silverberg; Benedicte A Lie; Marilynn Punaro; Richard K Russell; David C Wilson; Marla C Dubinsky; Dimitri S Monos; Vito Annese; Jane E Munro; Carol Wise; Helen Chapel; Charlotte Cunningham-Rundles; Jordan S Orange; Edward M Behrens; Kathleen E Sullivan; Subra Kugathasan; Anne M Griffiths; Jack Satsangi; Struan F A Grant; Patrick M A Sleiman; Terri H Finkel; Constantin Polychronakos; Robert N Baldassano; Eline T Luning Prak; Justine A Ellis; Hongzhe Li; Brendan J Keating; Hakon Hakonarson
Journal:  Nat Commun       Date:  2015-10-09       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.